Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-24 Sale |
2025-01-27 5:07 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
648 | $335.24 | $217,236 | 1,112,202 (Indirect Direct) |
View |
| 2025-01-17 Sale |
2025-01-17 7:05 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
1,689 | $273.41 | $461,789 | 1,112,850 (Indirect Direct) |
View |
| 2024-04-08 Sale |
2024-04-10 8:53 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
2,676 | $245.99 | $658,258 | 1,191,103 (Indirect Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 8:50 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
73,888 | $243.92 | $18,022,588 | 1,425,808 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-05 Option Award |
2025-03-07 5:00 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
11,763 | $0 | 1,123,965 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 8:53 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
2,676 | $0 | 1,191,103 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 8:53 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
2,676 | $9.45 | 1,191,103 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
73,888 | $0 | 1,425,808 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
73,888 | $9.45 | 1,425,808 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 5:54 pm |
N/A 2031-01-23 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
14,504 | $0 | 1,129,043 (Direct) |
View |
| 2024-01-16 Tax Withholding |
2024-01-18 1:46 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
1,546 | $243.92 | 1,108,753 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
20,001 | $0 | 1,110,299 (Direct) |
View |
Ownership |
2022-08-01 4:10 pm |
2021-03-29 2026-03-29 |
BriaCell Therapeutics Corp. | BCTX | Taub Rebecca Director |
0 | $0 | 20,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:12 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca See Remarks |
61,500 | $0 | 61,500 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-23 1:28 pm |
N/A 2031-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca See Remarks |
44,000 | $0 | 44,000 (Direct) |
View |